Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H23NO2 |
Molecular Weight | 309.4021 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]1(COC(O1)(C2=CC=CC=C2)C3=CC=CC=C3)[C@@]4([H])CCCCN4
InChI
InChIKey=HGKAMARNFGKMLC-MOPGFXCFSA-N
InChI=1S/C20H23NO2/c1-3-9-16(10-4-1)20(17-11-5-2-6-12-17)22-15-19(23-20)18-13-7-8-14-21-18/h1-6,9-12,18-19,21H,7-8,13-15H2/t18-,19+/m1/s1
Molecular Formula | C20H23NO2 |
Molecular Weight | 309.4021 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2555461
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2555461
Levoxadrol is an active enantiomer of dexoxadrol.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Stereospecific binding of 3H-phencyclidine in brain membranes. | 1982 Jun 21 |
|
Characterization of specific sigma opiate/phencyclidine (PCP)-binding sites in the human brain. | 1983 |
|
Comparison of the effects of the acute administration of dexoxadrol, levoxadrol, MK-801 and phencyclidine on body temperature in the rat. | 1989 Aug |
|
Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline. | 1992 Jul 1 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:43:52 GMT 2023
by
admin
on
Fri Dec 15 15:43:52 GMT 2023
|
Record UNII |
811X558HU0
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Fri Dec 15 15:43:52 GMT 2023 , Edited by admin on Fri Dec 15 15:43:52 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4792-18-1
Created by
admin on Fri Dec 15 15:43:52 GMT 2023 , Edited by admin on Fri Dec 15 15:43:52 GMT 2023
|
PRIMARY | |||
|
811X558HU0
Created by
admin on Fri Dec 15 15:43:52 GMT 2023 , Edited by admin on Fri Dec 15 15:43:52 GMT 2023
|
PRIMARY | |||
|
C005840
Created by
admin on Fri Dec 15 15:43:52 GMT 2023 , Edited by admin on Fri Dec 15 15:43:52 GMT 2023
|
PRIMARY | |||
|
14208378
Created by
admin on Fri Dec 15 15:43:52 GMT 2023 , Edited by admin on Fri Dec 15 15:43:52 GMT 2023
|
PRIMARY | |||
|
1503
Created by
admin on Fri Dec 15 15:43:52 GMT 2023 , Edited by admin on Fri Dec 15 15:43:52 GMT 2023
|
PRIMARY | |||
|
C66010
Created by
admin on Fri Dec 15 15:43:52 GMT 2023 , Edited by admin on Fri Dec 15 15:43:52 GMT 2023
|
PRIMARY | |||
|
DTXSID801023588
Created by
admin on Fri Dec 15 15:43:52 GMT 2023 , Edited by admin on Fri Dec 15 15:43:52 GMT 2023
|
PRIMARY | |||
|
100000082305
Created by
admin on Fri Dec 15 15:43:52 GMT 2023 , Edited by admin on Fri Dec 15 15:43:52 GMT 2023
|
PRIMARY | |||
|
SUB08496MIG
Created by
admin on Fri Dec 15 15:43:52 GMT 2023 , Edited by admin on Fri Dec 15 15:43:52 GMT 2023
|
PRIMARY | |||
|
CHEMBL306386
Created by
admin on Fri Dec 15 15:43:52 GMT 2023 , Edited by admin on Fri Dec 15 15:43:52 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |